Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfadimethoxine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | HTR6 | P50406 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.68 |
| ▸ | AKT1 | P31749 | 4/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.68 |
| ▸ | HTT | P42858 | 1/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.66 |
| ▸ | POLB | P06746 | 3/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.57 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.57 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.57 |
| ▸ | GFER | P55789 | 1/20 | 0.56 |
| ▸ | PDE4A | P27815 | 1/20 | 0.56 |
| ▸ | AGO2 | Q9UKV8 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfadimethoxine SCHEMBL29363944 | 1.00 | LMNA (1.00) | LMNAALDH1A1HTR6CYP3A4KMT2A | |
| Sulfadimethoxine SCHEMBL2430279 | 0.99 | LMNA (0.97) | LMNAALDH1A1HTR6CYP3A4KMT2A | |
| Sulfadimethoxine SCHEMBL9486265 | 0.95 | ALDH1A1 (0.90) | LMNAALDH1A1HTR6CYP3A4KMT2A | |
| Sulfadimethoxine SCHEMBL17102809 | 0.90 | LMNA (0.80) | LMNAALDH1A1HTR6CYP3A4KMT2A | |
| Sulfadimethoxine SCHEMBL6006340 | 0.90 | ALDH1A1 (0.80) | LMNAALDH1A1HTR6CYP3A4KMT2A | |
| Sulfadimethoxine SCHEMBL23928724 | 0.90 | ALDH1A1 (0.80) | LMNAALDH1A1HTR6CYP3A4KMT2A | |
| Sulfadimethoxine SCHEMBL28086139 | 0.88 | ALDH1A1 (0.77) | LMNAALDH1A1HTR6CYP3A4KMT2A | |
| SCHEMBL7824834 | 0.88 | ALDH1A1 (0.78) | LMNAALDH1A1HTR6CYP3A4KMT2A | |
| SCHEMBL7837632 | 0.88 | HTR6 (0.78) | LMNAALDH1A1HTR6CYP3A4KMT2A | |
| Sulfadimethoxine SCHEMBL13372563 | 0.87 | ALDH1A1 (0.76) | LMNAALDH1A1HTR6CYP3A4KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 8269 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091119-A1 | ISOLATED TARGETED DELIVERY SYSTEM FOR THE TREATMENT OF GLIOMA | CELLIS AG (CH) | 2026-04-02 | — | — | US | claimed |
| US-20260027140-A1 | COMPOSITIONS AND METHODS FOR TREATING AND AMELIORATING RESPIRATORY CONDITIONS AND INFLAMMATION OF MUCOSA | ATOPIC MEDICAL INC (US) | 2026-01-29 | — | — | US | claimed |
| US-12516365-B2 | Biocide compositions compatible with enzyme biosensors and methods of use thereof | INSTRUMENTATION LABORATORY COMPANY (US) | 2026-01-06 | — | — | US | claimed |
| US-12465623-B2 | Use of parasites and extracellular vesicles obtained from parasites in cancer treatment | YEDITEPE UNIVERSITESI (TR) | 2025-11-11 | — | — | US | claimed |
| EP-4637829-A1 | ISOLATED TARGETED DELIVERY SYSTEM FOR THE TREATMENT OF OVARIAN CANCER | Cellis Sp. z o.o. ([Ltd.] (PL) | 2025-10-29 | — | — | EP | claimed |
| EP-4630446-A1 | ENGINEERED SWITCHES FOR IMMUNE CELL ACTIVITY AND METHODS OF USE THEREOF | Dynamic Cell Therapies, Inc. (US) | 2025-10-15 | — | — | EP | claimed |
| EP-4630043-A1 | IMMUNE-ACTIVATING COMPLEXES | Dynamic Cell Therapies, Inc. (US) | 2025-10-15 | — | — | EP | claimed |
| US-20250314664-A1 | COMPOSITIONS AND METHODS TO DETECT INFECTIOUS ORGANISMS | MARS, INCORPORATED (US) | 2025-10-09 | — | — | US | claimed |
| EP-3965808-B1 | USE OF PARASITES AND EXTRACELLULAR VESICLES OBTAINED FROM PARASITES IN CANCER TREATMENT | UNIV YEDITEPE (TR) | 2025-09-03 | — | — | EP | claimed |
| EP-4594520-A2 | COMPOSITIONS CONTAINING OLIGONUCLEOTIDES WITH THERANOSTIC APPLICATIONS | Sixfold Bioscience Ltd. (GB) | 2025-08-06 | — | — | EP | claimed |
| US-4332796-A | MICROCRYSTALS COATED WITH MIXTURES OF PHOSPHOLIPIDS AND NONIONIC SURFACTANTS | LABORATORIOS BAGO S.A. (AR) | 1982-06-01 | — | — | US | claimed |
| US-4315931-A | MICROBIOCIDES, INFECTIOUS DISEASES | BASF AKTIENGESELLSCHAFT (DE) | 1982-02-16 | — | — | US | claimed |
| US-4277248-A | FORMATION OF SCHIFF BASE WITH P-DIMETHYLAMINOCINNAMALDEHYDE | HOFFMANN-LA ROCHE INC. (US) | 1981-07-07 | — | — | US | claimed |
| EP-0021847-A2 | Long acting sulfonamide injectable compositions | PFIZER INC. (US) | 1981-01-07 | — | — | EP | claimed |
| US-4169763-A | OF A CORYNEBACTERIA RESISTANT TO ASPARTIC ACID ANALOGS AND SULFA DRUGS | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1979-10-02 | — | — | US | claimed |
| US-4122158-A | FOR TREATMENT OF BURNS; BIODEGRADABLE HYDROPHOBIC POLYMER; SUSTAINED RELEASE | ALZA CORPORATION (US) | 1978-10-24 | — | — | US | claimed |
| US-4094976-A | ANTICOCCIDIAL CYCLICAMINO ETHANOLS AND ESTERS THEREOF | MERCK & CO., INC. (US) | 1978-06-13 | — | — | US | claimed |
| US-4044119-A | RUMINANTS, NATIVE MILK SOLIDS, DRUG ENTRAPMENT | CUTTER LABORATORIES, INC. (US) | 1977-08-23 | — | — | US | claimed |
| US-4041160-A | N-METHYL-2-PYRROLIDONE, ANTICOCCIDIAL AGENTS | ABIC LTD. (IL) | 1977-08-09 | — | — | US | claimed |
| US-3983209-A | HYDROPHOBIC BIOERODIBLE POLYMER, MICROBIOCIDE OR PROTEOLYTIC ENZYME | ALZA CORPORATION (US) | 1976-09-28 | — | — | US | claimed |